ARCHIVES

Pooled Analysis of Two LUX-Lung Trials Shows Prolonged Survival with Afatinib

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Cutting Back Support For Training Medical, Pediatric Oncologists; Clark Receives ACS Award

December 5, 1980

Henschke Responds To Articles On I-ELCAP.

January 12, 2007

Small Phase II Study Finds New Oral Agent May Slow Progression Of Difficult Cancer

April 24, 2009

Alan Davis to Retire From ACS; Five Execs Keep Top Positions

September 10, 1993

Funding Opportunities

September 27, 2002

Pastan’s Laboratory Creates “Chimeric” Monoclonal Antibody With Human, Muse

August 12, 1988